Abattis Bioceuticals Corp. (ABATTIS BIOCEUTICALS CORP) aksje
ATTBF
StengtABATTIS BIOCEUTICALS CORP
Market Cap
$14,334
Om Abattis Bioceuticals Corp. (ABATTIS BIOCEUTICALS CORP) aksje
Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.
Selskapsinformasjon
V6C 2M6 Vancouver, Canada
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.